Published in Hoppe Seylers Z Physiol Chem on December 01, 1981
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56
Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J (1983) 3.36
Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A (1982) 3.30
Structure and nucleotide sequence of the heavy chain gene of HLA-DR. Proc Natl Acad Sci U S A (1983) 3.21
cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain. Proc Natl Acad Sci U S A (1982) 2.80
Mutations and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J (1984) 2.34
Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains. EMBO J (1984) 2.18
A program for prediction of protein secondary structure from nucleotide sequence data: application to histocompatibility antigens. Nucleic Acids Res (1984) 2.02
The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins. Proc Natl Acad Sci U S A (1982) 1.80
Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex. Proc Natl Acad Sci U S A (1983) 1.78
Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay. Proc Natl Acad Sci U S A (1982) 1.77
Complete nucleotide sequence of a functional HLA-DP beta gene and the region between the DP beta 1 and DP alpha 1 genes: comparison of the 5' ends of HLA class II genes. Nucleic Acids Res (1985) 1.76
Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med (1982) 1.76
The complete nucleotide sequence of the I-E alpha d immune response gene. Nucleic Acids Res (1983) 1.75
Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Proc Natl Acad Sci U S A (1985) 1.70
Characterization of an HLA DR beta pseudogene. Proc Natl Acad Sci U S A (1985) 1.62
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line. EMBO J (1982) 1.46
Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes. J Exp Med (1985) 1.39
DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype. Proc Natl Acad Sci U S A (1985) 1.39
Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure. J Exp Med (1982) 1.34
Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1985) 1.34
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Differential expression of Ia molecules by human monocytes. J Clin Invest (1984) 1.15
Deletion mapping of HLA and chromosome 6p genes. Proc Natl Acad Sci U S A (1985) 1.11
Use of synthetic oligonucleotide probes complementary to genes for human HLA-DR alpha and beta as extension primers for the isolation of 5'-specific genomic clones. Proc Natl Acad Sci U S A (1983) 1.09
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis. Proc Natl Acad Sci U S A (1985) 1.04
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med (1982) 1.03
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med (1982) 0.92
Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes. Proc Natl Acad Sci U S A (1987) 0.89
Distinct populations of class II molecules identified by monoclonal antibodies. Clin Exp Immunol (1983) 0.82
Interpretation of the specificities of monoclonal antibodies recognising human MHC class II antigens. Clin Exp Immunol (1985) 0.79
A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens. J Exp Med (1983) 0.79
Activated T cells in Graves' disease before treatment. Clin Exp Immunol (1985) 0.78
Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science (1987) 4.98
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med (1975) 4.96
Amino acid sequence studies with Bence-Jones proteins. Proc Natl Acad Sci U S A (1965) 4.53
Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature (1999) 4.15
Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest (1974) 3.24
CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int (2007) 3.01
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med (1972) 2.47
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol (2001) 2.20
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol (2004) 2.01
CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J (1998) 1.95
[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch Med Wochenschr (2001) 1.91
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature (1986) 1.85
Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med (1983) 1.84
The neural cell adhesion molecule N-CAM enhances L1-dependent cell-cell interactions. J Cell Biol (1990) 1.74
Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye (Lond) (2004) 1.70
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer (1982) 1.67
Human B cell development. II. Subpopulations in the human fetus. J Immunol (1985) 1.67
[The complete amino acid sequence of Bence Jones protein New (lambda-type). Subgroups in the variable part of immunoglobulin L-chains of the lambda-type]. Hoppe Seylers Z Physiol Chem (1968) 1.67
HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol (1988) 1.63
TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci U S A (1991) 1.53
Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin. J Biol Chem (2001) 1.52
Congenital infections with human herpesvirus 6. J Infect Dis (1998) 1.51
Human Ia-type alloantigens: methods of detection, aspects of chemistry and biology, markers for disease states. Transplant Rev (1976) 1.48
Absence of a seasonal variation in myocardial infarction onset in a region without temperature extremes. Cardiology (1998) 1.48
In vitro elution of antibiotic from antibiotic-impregnated biodegradable calcium alginate wound dressing. J Trauma (1999) 1.47
CD24 is a marker for human breast carcinoma. Cancer Lett (1999) 1.45
Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy (2008) 1.44
Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts. J Biol Chem (1999) 1.44
Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol (1967) 1.43
Studies on human porin. III. Does the voltage-dependent anion channel "Porin 31HL" form part of the chloride channel complex, which is observed in different cells and thought to be affected in cystic fibrosis? Biol Chem Hoppe Seyler (1990) 1.42
Clonal culture of fetal cells from maternal blood. Lancet (2000) 1.41
Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med (1990) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
[The primary structure of a monoclonal IgM-immunoglobulin (macroglobulin Gal.), II: the amino acid sequence of the H-chain (mu-type), subgroup H III. Architecture of the complete IgM-molecule (author's transl)]. Hoppe Seylers Z Physiol Chem (1975) 1.37
Pathogenesis and immunology of trachoma. Trans Assoc Am Physicians (1972) 1.37
Complete membranous obstruction of the inferior vena cava: clinical characteristics of Chinese patients. J Intern Med (1993) 1.37
Depressive symptoms and mortality in elderly persons. J Gerontol (1992) 1.37
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res (2000) 1.31
Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem (2000) 1.30
Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med (1991) 1.29
Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. J Immunol (1982) 1.27
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis (1971) 1.27
Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol Chem Hoppe Seyler (1994) 1.27
Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens. Immunobiology (1986) 1.24
Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res (1983) 1.24
[The primary structure of human free secretory component and the arrangement of disulfide bonds]. Hoppe Seylers Z Physiol Chem (1984) 1.22
[In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells]. Orthopade (2004) 1.21
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation. Ann Oncol (2012) 1.21
Clinical evaluation of the Taiwan trachoma control programme. Bull World Health Organ (1971) 1.21
Structural changes in human dental enamel after subablative erbium laser irradiation and its potential use for caries prevention. Caries Res (2004) 1.21
Bacteremia in patients with cirrhosis of the liver. Liver (1991) 1.20
Changes in phases and crystallinity of plasma-sprayed hydroxyapatite coatings under heat treatment: a quantitative study. J Biomed Mater Res (1995) 1.20
Specific concentration of antilymphocyte antibodies in the serum cryoprecipitates of patients with systemic lupus erythematosus. Clin Exp Immunol (1975) 1.19
High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant (2005) 1.19
Association of CD2 and CD45 on human T lymphocytes. Nature (1990) 1.18
HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation. J Biol Chem (1999) 1.18
The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum. Aust J Exp Biol Med Sci (1971) 1.17
Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer. J Chronic Dis (1987) 1.17
Identification of cord blood dendritic cells as an immature CD11c- population. Blood (1999) 1.16
Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol (1995) 1.14
Separation of phenylthiocarbamyl amino acids by high-performance liquid chromatography on Spherisob octadecylsilane columns. J Chromatogr (1985) 1.14
Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am J Ophthalmol (1967) 1.14
The L1 adhesion molecule is a cellular ligand for VLA-5. J Cell Biol (1995) 1.14
Functional cooperation between the neural adhesion molecules L1 and N-CAM is carbohydrate dependent. J Cell Biol (1990) 1.14
The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene (2007) 1.14
Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents. J Neurosci Res (2000) 1.14
Influence of cysteine to cysteic acid oxidation on the collision-activated decomposition of protonated peptides: Evidence for intraionic interactions. J Am Soc Mass Spectrom (1992) 1.13
Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol (2007) 1.13
Heat-stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function. Eur J Immunol (1994) 1.13
Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -- a Eurocord analysis. Br J Haematol (2001) 1.12
Growth reduction of Listeria spp. caused by undefined industrial red smear cheese cultures and bacteriocin-producing Brevibacterium lines as evaluated in situ on soft cheese. Appl Environ Microbiol (1997) 1.12
Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture. J Immunol (1981) 1.12
[The primary structure of a monoclonal IgA-immunoglobulin (IgA Tro.), II. The amino acid sequence of the H-chain, alpha-type, subgroup III; structure of the complete IgA-molecule (author's transl)]. Hoppe Seylers Z Physiol Chem (1975) 1.11
Magnetically enhanced high-specificity virus detection using bio-activated magnetic nanoparticles with antibodies as labeling markers. J Virol Methods (2009) 1.11
Two-stage cementless revision THR after infection. 5 recurrences in 40 cases followed 2.5-7 years. Acta Orthop Scand (1996) 1.11
Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro. Biol Chem Hoppe Seyler (1993) 1.11
Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol (1994) 1.09
Antigenic variation in cancer metastasis: immune escape versus immune control. Cancer Metastasis Rev (1982) 1.09
Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant. Eur J Immunol (1982) 1.09
Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein. Biol Chem Hoppe Seyler (1994) 1.08
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1). Hoppe Seylers Z Physiol Chem (1983) 1.08